2022 Annual Meeting of the NCI Cohort Consortium (Agenda)

Agenda

 

Day 1, Tuesday, November 1, 2022 (8:00–11:45 a.m. ET)

8:00–8:40

Opening Remarks and Acknowledgements
Dr. Kathy Helzlsouer, National Cancer Institute, NIH
Dr. Heather Eliassen, Harvard Medical School and Harvard School of Public Health

Welcoming Remarks from the National Cancer Institute

Dr. Katrina Goddard, Director, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH

Dr. Stephen Chanock, Director, Division of Cancer Epidemiology & Genetics (DCEG), National Cancer Institute, NIH 

Dr. Emily Tonorezos, Director, Office of Cancer Survivorship, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH

8:40–9:45

SESSION I: DATA SHARING 

 

Moderator: 
Dr. Kathy Helzlsouer, National Cancer Institute, NIH
Dr. Jessica Petrick, Boston University School of Medicine

8:40–8:55

NIH Data Sharing Policy Update
Dr. Julia Slutsman, Genomic Data Sharing Policy Implementation, Office of Extramural Research, NIH

Dr. Nonye Harvey, Genomic Data Sharing Policy Implementation, Office of Extramural Research, NIH

8:55–9:15

Advances in Data Science from the NIH perspective
Dr. Susan Gregurick, Office of Data Science Strategy (ODSS), NIH

9:15–9:35

Virtual Pooled Registry Cancer Linkage System: Current and Future Initiatives
Ms. Castine Clerkin, North American Association of Central Cancer Registries

9:35–9:45 Q & A Session

9:45–10:00

Break

10:00–11:30

SESSION II: CHALLENGES AND OPPORTUNITIES FOR COHORTS OF CANCER SURVIVORS

 

Moderators:
Dr. Joanne Elena, National Cancer Institute, NIH
Dr. Traci Bethea, Georgetown Lombardi Comprehensive Cancer Center

10:00–11:00

Cohort Overview

Lymphoma Epidemiology of Outcomes (LEO) Cohort
Dr. James Cerhan, Mayo Clinic College of Medicine and Science

England & Wales Hodgkin Lymphoma Cohort
Dr. Aislinn Macklin-Doherty, The Royal Marsden NHS Foundation Trust

ColoCare Consortium (ColoCare)
Dr. Neli Ulrich, Comprehensive Cancer Center at Huntsman Cancer Institute

Pathways Study
Dr. Larry Kushi, Kaiser Permanente Northern California

Susan G. Komen Tissue Bank
Ms. Jill Henry, IU Simon Comprehensive Cancer Center

11:00–11:30 Panel Discussion
11:30–11:45

Associate Member Council Update

Dr. Lauren E. McCullough, Emory University

11:45 Adjourn 
12:00–12:45

Brown Bag Networking Session Hosted by Early Career Scientists (optional)

 

Day 2, Wednesday, November 2, 2022 (1:00–5:00 p.m. ET)

12:00–12:45 General Brown Bag Networking Session (optional) 

1:00–1:05

Opening Remarks 
Dr. Kathy Helzlsouer, National Cancer Institute, NIH

1:05–1:45

Plenary Session - State of the Science in Survivorship Research
Dr. Patricia A. Ganz, UCLA School of Medicine and Public Health and UCLA Jonsson Comprehensive Cancer Center

1:45–2:00 Q & A Session
2:00–3:15

SESSION III: DATA COLLECTION, ACCESS, AND LINKAGES

 

Moderators: 
Dr. Erika Rees-Punia, American Cancer Society
Dr. Mia Gaudet, National Cancer Institute, NIH

2:00–2:20

Perspectives on CMS linkage for Cancer Research in Cohort Studies
Dr. Janet Olson, Mayo Clinic College of Medicine
Dr. V. Wendy Setiawan, University of Southern California

2:20–2:35 Q & A Session

2:35–3:05

The All of Us Research Program- Data Types, Data Access, Data Analysis
Dr. Sheri Schully, All of Us Research Program, NIH
Dr. Geoffrey Ginsburg, All of Us Research Program, NIH

3:05–3:15 Q & A Session
3:15–3:35

Research Facilitation Report

Dr. Roger Milne, Cancer Council Victoria

3:35–3:50 Break
3:50–4:50

SESSION IV: COHORT CONSORTIUM PROJECT GROUP REPORT BACKS

 

Moderators: 
Dr. Jeannette Schenk, Fred Hutchinson Cancer Research Center
Dr. Melissa Merritt, University of Hawaii Cancer Center

Sexual and Gender Minority Interest Group
Dr. Sarah S. Jackson, National Cancer Institute, NIH

The Breast Cancer Risk Prediction Project
Dr. Peter Kraft, Harvard T.H. Chan School of Public Health

Prostate Cancer Cohort Consortium (PC3): A collaborative approach to an enigmatic cancer
Dr. Konrad Stopsack, Harvard T.H. Chan School of Public Health
Dr. Eboneé Butler, University of North Carolina

Lung Cancer Cohort Consortium (LC3) 
Dr. Mathias Johannson, International Agency for Research Cancer (IARC)

Linking the Liver Cancer Pooling Project (LCPP) with the Diet Pooling Project (DCPP)
Dr. Jessica Petrick, Boston University

Investigating the role of immune markers in driving sex-specific differences in Glioblastoma (GBM) development
Dr. Kristin Waite, National Cancer Institute, NIH

4:50 Adjourn